Adaptive Biotechnologies Corp Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 294,720 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 294,720 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 311,400 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 16,680 | 5,504 | 311,400 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 20,668 | 6,820 | 328,080 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 20,668 | 6,820 | 328,080 | |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.79 | 1,200 | 45,348 | 1,778,180 | 1.8 M to 1.8 M (-0.07 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.79 | 1,200 | 45,348 | 1,778,180 | 1.8 M to 1.8 M (-0.07 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.19 | 15,480 | 575,701 | 1,779,380 | 1.8 M to 1.8 M (-0.86 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.19 | 15,480 | 575,701 | 1,779,380 | 1.8 M to 1.8 M (-0.86 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.96 | 9,884 | 375,197 | 1,778,180 | 1.8 M to 1.8 M (-0.55 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.96 | 9,884 | 375,197 | 1,778,180 | 1.8 M to 1.8 M (-0.55 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.48 | 6,796 | 254,714 | 1,788,064 | 1.8 M to 1.8 M (-0.38 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 37.48 | 6,796 | 254,714 | 1,788,064 | 1.8 M to 1.8 M (-0.38 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 16,680 | 5,504 | 1,794,860 | 1.8 M to 1.8 M (+0.94 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 38.14 | 20,668 | 788,278 | 1,778,180 | 1.8 M to 1.8 M (-1.15 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 38.14 | 20,668 | 788,278 | 1,778,180 | 1.8 M to 1.8 M (-1.15 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 20,668 | 6,820 | 1,798,848 | 1.8 M to 1.8 M (+1.16 %) |
| Jul 31 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 20,668 | 6,820 | 1,798,848 | 1.8 M to 1.8 M (+1.16 %) |
| Jul 24 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,771 | 11,600 | 35,417 | |
| Jul 24 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,109 | 8,650 | 38,363 | |
| Jul 24 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 36.03 | 2,880 | 103,766 | 1,300 | 4.2 K to 1.3 K (-68.90 %) |
| Jul 24 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,771 | 11,600 | 4,180 | 2.4 K to 4.2 K (+73.52 %) |
| Jul 24 2020 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,109 | 8,650 | 2,409 | 1.3 K to 2.4 K (+85.31 %) |
| Jul 22 2020 | ADPT | Adaptive Biotechno ... | GOEL DAVID E. | Director | Sell | S | 40.00 | 2,000,000 | 80,000,000 | 13,115,090 | 15.1 M to 13.1 M (-13.23 %) |
| Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 3,750 | |
| Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 40.00 | 417 | 16,680 | 0 | 417 to 0 (-100.00 %) |
| Jul 21 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 196,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 196,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 44.56 | 500 | 22,280 | 0 | 500 to 0 (-100.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 44.56 | 500 | 22,280 | 0 | 500 to 0 (-100.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 43.62 | 1,500 | 65,430 | 500 | 2 K to 500 (-75.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 43.62 | 1,500 | 65,430 | 500 | 2 K to 500 (-75.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 366,900 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 366,900 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 22,200 | 140,304 | 378,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 22,200 | 140,304 | 378,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.23 | 1,706 | 68,632 | 679 | 2.4 K to 679 (-71.53 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 40.23 | 1,706 | 68,632 | 679 | 2.4 K to 679 (-71.53 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.62 | 8,194 | 324,646 | 2,385 | 10.6 K to 2.4 K (-77.46 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.62 | 8,194 | 324,646 | 2,385 | 10.6 K to 2.4 K (-77.46 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.61 | 1,200 | 46,332 | 10,579 | 11.8 K to 10.6 K (-10.19 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 38.61 | 1,200 | 46,332 | 10,579 | 11.8 K to 10.6 K (-10.19 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.92 | 7,380 | 294,610 | 679 | 8.1 K to 679 (-91.57 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.92 | 7,380 | 294,610 | 679 | 8.1 K to 679 (-91.57 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.39 | 14,820 | 583,760 | 8,059 | 22.9 K to 8.1 K (-64.78 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 39.39 | 14,820 | 583,760 | 8,059 | 22.9 K to 8.1 K (-64.78 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 22,200 | 140,304 | 22,879 | 679 to 22.9 K (+3,269.51 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 22,200 | 140,304 | 22,879 | 679 to 22.9 K (+3,269.51 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 69,000 | |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 44.58 | 500 | 22,290 | 0 | 500 to 0 (-100.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 43.60 | 1,500 | 65,400 | 500 | 2 K to 500 (-75.00 %) |
| Jul 17 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 640,000 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 47.52 | 2,104 | 99,982 | 1,000 | 3.1 K to 1,000 (-67.78 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 46.82 | 27,896 | 1,306,091 | 3,104 | 31 K to 3.1 K (-89.99 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 15,275 | 12,831 | 94,725 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 15,275 | 748,475 | 0 | 15.3 K to 0 (-100.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 15,275 | 12,831 | 15,275 | 0 to 15.3 K |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 17,400 | 14,616 | 100,600 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 49.00 | 17,400 | 852,600 | 10,000 | 27.4 K to 10 K (-63.50 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 17,400 | 14,616 | 27,400 | 10 K to 27.4 K (+174.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.32 | 30,000 | 189,600 | 640,000 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 47.52 | 2,104 | 99,982 | 1,000 | 3.1 K to 1,000 (-67.78 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 46.82 | 27,896 | 1,306,091 | 3,104 | 31 K to 3.1 K (-89.99 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.32 | 30,000 | 189,600 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 15,275 | 12,831 | 94,725 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 15,275 | 748,475 | 0 | 15.3 K to 0 (-100.00 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 15,275 | 12,831 | 15,275 | 0 to 15.3 K |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 17,400 | 14,616 | 100,600 | |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 49.00 | 17,400 | 852,600 | 10,000 | 27.4 K to 10 K (-63.50 %) |
| Jul 10 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 17,400 | 14,616 | 27,400 | 10 K to 27.4 K (+174.00 %) |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 55,000 | |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 47.98 | 400 | 19,192 | 0 | 400 to 0 (-100.00 %) |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 47.34 | 9,600 | 454,464 | 400 | 10 K to 400 (-96.00 %) |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 10,000 | 63,200 | 10,000 | 0 to 10 K |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Option Exercise | M | 7.80 | 6,250 | 48,750 | 437,500 | |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 48.42 | 200 | 9,684 | 0 | 200 to 0 (-100.00 %) |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Sell | S | 47.29 | 6,050 | 286,105 | 200 | 6.3 K to 200 (-96.80 %) |
| Jul 08 2020 | ADPT | Adaptive Biotechno ... | BALDO LANCE | Chief Medical Offic ... | Buy | M | 7.80 | 6,250 | 48,750 | 6,250 | 0 to 6.3 K |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,563 | 11,363 | 46,875 | |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 70,313 | |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 41,667 | |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.13 | 1,200 | 57,756 | 0 | 1.2 K to 0 (-100.00 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.17 | 5,571 | 262,784 | 1,200 | 6.8 K to 1.2 K (-82.28 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,563 | 11,363 | 6,771 | 5.2 K to 6.8 K (+30.01 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 5,208 | 2.6 K to 5.2 K (+100.00 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Option Exercise | M | 0.84 | 3,000 | 2,520 | 118,000 | |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 48.01 | 1,200 | 57,612 | 10,000 | 11.2 K to 10 K (-10.71 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Sell | S | 47.03 | 1,800 | 84,654 | 11,200 | 13 K to 11.2 K (-13.85 %) |
| Jul 02 2020 | ADPT | Adaptive Biotechno ... | HILL NANCY LOUISE | EVP, Operations & P ... | Buy | M | 0.84 | 3,000 | 2,520 | 13,000 | 10 K to 13 K (+30.00 %) |
| Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.32 | 417 | 2,635 | 417 | |
| Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 47.42 | 417 | 19,774 | 0 | 417 to 0 (-100.00 %) |
| Jul 01 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.32 | 417 | 2,635 | 417 | 0 to 417 |